Cargando…
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
INTRODUCTION: Budesonide-formoterol taken as needed is an emerging treatment for mild asthma. OBJECTIVE: We used data from the SYGMA studies to assess the safety of As-needed budesonide-formoterol compared with As-needed terbutaline and compared with maintenance budesonide. METHODS: SYGMA 1 and 2 we...
Autores principales: | FitzGerald, J. Mark, O’Byrne, Paul M., Bateman, Eric D., Barnes, Peter J., Zheng, Jinping, Ivanov, Stefan, Lamarca, Rosa, Larsdotter, Ulrika, Emerath, Ulrika, Jansen, Gerreke, Puu, Margareta, Alagappan, Vijay K. T., Surmont, Filip, Reddel, Helen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994217/ https://www.ncbi.nlm.nih.gov/pubmed/33548020 http://dx.doi.org/10.1007/s40264-020-01041-z |
Ejemplares similares
-
Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
por: Bateman, Eric D., et al.
Publicado: (2021) -
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
por: O’Byrne, Paul M., et al.
Publicado: (2017) -
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017) -
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
por: Bateman, Eric D, et al.
Publicado: (2011) -
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)